CGIM
INBX icon

Cannon Global Investment Management’s Inhibrx INBX Stock Holding History

Cannon Global Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Buy
+5,900
New +$591K 1.58% 30

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
PCM
Presidio Capital Management San Diego, California $400M AUM 22.73% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Cannon Global Investment Management's INBX Position: Q2 2026 in Review

Cannon Global Investment Management opened a new position in Inhibrx (INBX) in Q2 2026: 5,900 shares worth $559K. The stake represents 1.58% of the portfolio and ranks #30 among its holdings.

23 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Cannon Global Investment Management held 5,900 shares of Inhibrx worth $559K as of Q2 2026.
  • Inhibrx was a new Cannon Global Investment Management position in Q2 2026.
  • Inhibrx made up 1.58% of Cannon Global Investment Management's portfolio in Q2 2026, its #30 holding.
  • 23 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Cannon Global Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.